Robert Holloway, MD | Authors

Articles

Racial Disparities and Unmet Needs in Endometrial Cancer

January 19, 2023

Video

Robert Holloway, MD, highlights the issue of racial disparity in endometrial cancer, and the critical unmet needs for patients.

Second-Line Treatment Goals and Adverse Event Management for Patients with Metastatic Endometrial Cancer

January 19, 2023

Video

Insights into the goals of second-line therapy for patients with advanced/recurrent endometrial carcinoma, and best strategies for adverse event management.

Selecting an Appropriate Second-Line Treatment for Metastatic Endometrial Cancer

January 19, 2023

Video

Dr Robert Holloway explains what second-line treatment regimen he would have chosen for the patient with metastatic endometrial cancer in the presented case.

KEYNOTE-775: Lenvatinib/Pembrolizumab in Patients with Advanced Endometrial Carcinoma

January 19, 2023

Video

Robert Holloway, MD, review safety and efficacy data from a clinical trial investigation of lenvatinib combined with pembrolizumab for the treatment of advanced endometrial cancer.

Available Systemic Therapy Options for Patients with MMR-Proficient Metastatic Endometrial Cancer

January 19, 2023

Video

An expert details the currently available systemic therapies for patients with MMR-proficient metastatic endometrial cancer who experienced recurrent disease after platinum-based chemotherapy.

Presentation of Endometrial Cancer and MMR Testing

January 19, 2023

Video

Dr Robert Holloway describes the presentation of a typical patient with metastatic endometrial cancer, and whether all patients receive MMR testing.